IIAEK Targets Intestinal Alkaline Phosphatase (IAP) to Improve Cholesterol Metabolism with a Specific Activation of IAP and Downregulation of ABCA1
IIAEK (Ile-Ile-Ala-Glu-Lys, lactostatin) is a novel cholesterol-lowering pentapeptide derived from bovine milk β-lactoglobulin. However, the molecular mechanisms underlying the IIAEK-mediated suppression of intestinal cholesterol absorption are unknown. Therefore, we evaluated the effects of IIAEK o...
Main Authors: | Asahi Takeuchi, Kentaro Hisamatsu, Natsuki Okumura, Yuki Sugimitsu, Emiko Yanase, Yoshihito Ueno, Satoshi Nagaoka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/9/2859 |
Similar Items
-
Intestinal alkaline phosphatase (IAP, IAP Enhancer) attenuates intestinal inflammation and alleviates insulin resistance
by: Chenzhe Gao, et al.
Published: (2022-07-01) -
Origins of intestinal ABCA1-mediated HDL-cholesterol*
by: F. Jeffrey Field, et al.
Published: (2008-12-01) -
Effects of ABCA1 Gene Polymorphisms on Lipid Profile in a Scottish Population
by: A Pasdar, et al.
Published: (2005-03-01) -
Effects of ABCA1 Gene Polymorphisms on Lipid Profile in a Scottish Population
by: A Pasdar, et al.
Published: (2005-10-01) -
Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments
by: Quentin Spillier, et al.
Published: (2021-01-01)